Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07796204 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ability of Almonds to Improve Nutrition During GLP-1 Treatment

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This 8-week randomized controlled pilot trial is to test the hypothesis that, compared to a Usual Diet control group, almond intake will increase vitamin E (alpha-tocopherol) levels in the blood and improve diet quality (Healthy Eating Index) among people prescribed a glucagon-like peptide-1. Two groups of individuals will either: 1) consume a minimum of 56 grams of almonds each day, or 2) not consume almonds and follow their usual diet.
Trial Details
NCT Number NCT07796204
Lead Sponsor Pennington Biomedical Research Center
Collaborators: Almond Board of California
Conditions
(from sponsor)		 Obesity, Type 2 Diabetes
Related terms Diabetes Mellitus, Type 2, Obesity
Enrollment 76 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov